Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

220 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Active, Not Recruiting

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

NCT06843239

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +9 more
Locations
  • UCSD Altman Clinical and Translational Research Institute Center for Clinical Research La Jolla, California, United States
  • UCLA Department of Medicine Los Angeles, California, United States
  • IRIS Research and Development LLC Plantation, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

NCT05270668

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease, +7 more
Locations
  • Mayo Clinic - Scottsdale ( Site 4014) Phoenix, Arizona, United States
  • Pacific Arthritis Care Center ( Site 4008) Los Angeles, California, United States
  • Cedars Sinai Medical Center ( Site 4010) Los Angeles, California, United States
  • UCLA School of Medicine ( Site 4006) Los Angeles, California, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT06025578

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +23 more
Locations
  • Local Institution - 0046 Birmingham, Alabama, United States
  • Local Institution - 0314 Phoenix, Arizona, United States
  • Local Institution - 0336 La Jolla, California, United States
  • Local Institution - 0212 Los Angeles, California, United States
View all 459 locations
View Trial Details
Active, Not Recruiting

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

NCT02682511

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +8 more
Locations
  • The Universtity of Arizona Arthrtis Center Tucson, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Cleveland Clinic - Florida Weston, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

NCT06255028

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +27 more
Locations
  • Keck School of Medicine of University of Southern California Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Lurie Children's; Northwestern Medicine - Northwestern Medical Group Chicago, Illinois, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions